Evidence map›Paper›PMID 33268892›Full record

ArticleNature2021

ALDH4A1 is an atherosclerosis auto-antigen targeted by protective antibodies.

Cristina Lorenzo, Pilar Delgado, Christian E Busse, Alejandro Sanz-Bravo, Inmaculada Martos-Folgado, Elena Bonzon-Kulichenko, Alessia Ferrarini, Ileana B Gonzalez-Valdes, Sonia M Mur, Raquel Roldán-Montero and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 2 syntheses or guidelines pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. B cells promote atrial fibrillation via autoantibodies.Nature cardiovascular research · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Expression Cloning of Antibodies from Single Human B Cells.Methods in molecular biology (Clifton, N.J.) · 2025
    Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Cristina LorenzoB Lymphocyte Biology Lab, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Pilar DelgadoB Lymphocyte Biology Lab, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.ORCID http://orcid.org/0000-0002-8431-8002
Christian E Busse *Division of B Cell Immunology, German Cancer Research Center, Heidelberg, Germany.ORCID http://orcid.org/0000-0001-7553-905X
Alejandro Sanz-Bravo *B Lymphocyte Biology Lab, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Inmaculada Martos-Folgado *B Lymphocyte Biology Lab, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Elena Bonzon-Kulichenko *Cardiovascular Proteomics Lab, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Alessia FerrariniCardiovascular Proteomics Lab, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.ORCID http://orcid.org/0000-0002-4587-6095
Ileana B Gonzalez-ValdesCardiovascular Proteomics Lab, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Sonia M MurB Lymphocyte Biology Lab, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Raquel Roldán-MonteroVascular Pathology Lab, IIS-Fundación Jiménez Díaz-Universidad Autónoma, Madrid, Spain.
Diego Martinez-LopezVascular Pathology Lab, IIS-Fundación Jiménez Díaz-Universidad Autónoma, Madrid, Spain.
Jose L Martin-VenturaCIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Jesús VázquezCardiovascular Proteomics Lab, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.ORCID http://orcid.org/0000-0003-1461-5092
Hedda WardemannDivision of B Cell Immunology, German Cancer Research Center, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-3921-5933
Almudena R RamiroB Lymphocyte Biology Lab, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. aramiro@cnic.es.ORCID http://orcid.org/0000-0002-7539-3844
Spanish National Centre for Cardiovascular Research · ESGerman Cancer Research Center · DEHospital Universitario Fundación Jiménez Díaz · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESConsejo Superior de Investigaciones Científicas · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular disease (CVD) is the leading cause of mortality in the world, with most CVD-related deaths resulting from myocardial infarction or stroke. The main underlying cause of thrombosis and cardiovascular events is atherosclerosis, an inflammatory disease that can remain asymptomatic for long periods. There is an urgent need for therapeutic and diagnostic options in this area. Atherosclerotic plaques contain autoantibodies

Indexed as

1-Pyrroline-5-Carboxylate DehydrogenaseAnimalsAtherosclerosisAutoantibodiesAutoantigensAutoimmunityBiomarkersB-LymphocytesCholesterolDiet, High-FatDisease Models, AnimalDisease ProgressionHumansLipoproteins, LDLMaleMice1-Pyrroline-5-Carboxylate DehydrogenaseALDH4A1 protein, humanAutoantibodiesAutoantigensBiomarkersCholesterolLipoproteins, LDLReceptors, LDL

Identifiers

PMID33268892
OpenAlexW3109298913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.